Trinity Bio-Tech Profile
Key Indicators
- Authorised Capital ₹ 6.50 Cr
as on 05-12-2024
- Paid Up Capital ₹ 3.33 Cr
as on 05-12-2024
- Company Age 36 Year, 9 Months
- Last Filing with ROC 31 Mar 2021
- Open Charges ₹ 4.65 Cr
as on 05-12-2024
- Revenue 16.47%
(FY 2020)
- Profit -38.95%
(FY 2020)
- Ebitda -37.00%
(FY 2020)
- Net Worth 0.32%
(FY 2020)
- Total Assets 1.64%
(FY 2020)
About Trinity Bio-Tech
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2021. It's a company limited by shares with an authorized capital of Rs 6.50 Cr and a paid-up capital of Rs 3.33 Cr.
The company currently has active open charges totaling ₹4.65 Cr.
Dilip Rajkumar, Rohit Bajaj, Arunkumar Bajaj, and One other member serve as directors at the Company.
- CIN/LLPIN
U51900MH1988PLC046446
- Company No.
046446
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
08 Mar 1988
- Date of AGM
30 Nov 2021
- Date of Balance Sheet
31 Mar 2021
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Trinity Bio-Tech?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Arunkumar Bajaj  | Director | 09-Mar-1988 | Current |
| Dilip Rajkumar | Director | 30-Mar-2019 | Current |
| Rohit Bajaj | Additional Director | 06-Jan-2023 | Current |
| Asha Upadhyay | Director | 30-Mar-2019 | Current |
Financial Performance of Trinity Bio-Tech.
Trinity Bio-Tech Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 16.47% increase. The company also saw a substantial fall in profitability, with a 38.95% decrease in profit. The company's net worth moved up by a moderate rise of 0.32%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Trinity Bio-Tech?
In 2019, Trinity Bio-Tech had a promoter holding of 34.83% and a public holding of 65.18%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Maytag Production Private LimitedActive 43 years 6 monthsDilip Rajkumar, Rohit Bajaj and 2 more are mutual person
- Jlr Broking Securities Services Private LimitedActive 9 years 2 months
Dilip Rajkumar is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Central Bank Of India Creation Date: 28 Oct 1996 | ₹3.00 M | Open |
Central Bank Of India Creation Date: 25 Sep 1995 | ₹4.00 Cr | Open |
Central Bank Of India Creation Date: 07 Apr 1993 | ₹0.55 M | Open |
How Many Employees Work at Trinity Bio-Tech?
Unlock and access historical data on people associated with Trinity Bio-Tech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Trinity Bio-Tech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Trinity Bio-Tech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
